Published in Vaccine Weekly, June 14th, 2006
Study 1: Incorporation of pepstatin into culture media reduces protease activity in filtrates from Aspergillus niger NRRL-3.
According to recent research from Canada, "Aspergillus species have been used in different industrial applications including extracellular enzyme production and as potential hosts for recombinant heterologous proteins production because of their excellent growth and fermentation properties. However, recombinant protein production levels are typically low due to the impact of Aspergillus proteases in modifying and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.